3Année·

I am again looking for future topics from the healthcare sector. In the process, I came across Dexcom. This company is a leading manufacturer of continuously measuring glucose probes.


Diabetes is one of the widespread diseases that entails long-term and costly treatment and therapy. With this background, Dexcom's business model fills exactly this gap.


What do you think?

6 Commentaires

Utilisateur supprimé
3Année
Le commentaire a été supprimé
image de profil
@MarcoInvest95 Abbott is the market power in this field. Dexcom's valuation is sporty, I agree with you. 😁
Utilisateur supprimé
3Année
Le commentaire a été supprimé
image de profil
@MarcoInvest95 Good point. I'll have to take a close look at those. Figures from Abbott are also very solid.
Utilisateur supprimé
3Année
Le commentaire a été supprimé
image de profil
@MarcoInvest95 I'll put them on my WL :-). Sounds good.
Participez à la conversation